Essential Steps to Successful Biopharma Partnering
Valuation of Your Early Drug Candidate
Getting Ready for a Biopharma Partnering Deal
The Nuts & Bolts of Due Diligence in Biopharma Partnering
What's Hot and What's Not in Oncology Licensing in 2020?
How to Win at the Partnering Game
In this white paper, Linda Pullan provides a review of the rules of the partnering game – whether it’s partnering from preclinical to late clinical development – to provide an understanding of what to expect in moving from introductions to negotiations of a license or acquisition and how to win with a clear strategy.
What’s Hot & What’s Not in Immuno-Oncology Licensing
Non-Immuno-Oncology and Immuno-Oncology Partnering and Development: What’s the Role of Non-IO in an IO World?
What’s Hot & What’s Not in Oncology Licensing in 2020?
Building a Better Partnering Presentation
Whether seeking a partnership with another company to obtain funds, or looking to advance a drug candidate or technology, organizations need to present opportunities as attractively as possible to persuade potential partners.
What's Hot & What's Not in Antibody Drug Conjugates Licensing
In this whitepaper, learn what targets are suitable, what are the trends in linkers and the drugs to be attached to the antibodies, what are the indications being pursued, how are companies dealing with the complexities of internalization and high cost of goods, what kind of data will drive an ADC licensing deal, how do the ADCs fit in the world of immuno-oncology and what is the future for ADCs.
Building a Successful Business Development and Licensing Strategy
This white paper provides several topics to consider before investing in, planning and executing a business development initiative and the challenges presented by organizational structure and the importance of goal setting, flexibility and story-telling in a business context.